Zeyad Ibrahim

Zeyad Ibrahim is a Doctor of Philosophy student at the University of Western Australia, engaged in Casual Teaching and acting as a Multi-Discipline Contractor/Visitor. Affiliated with the School of Allied Health, UWA Medical School, and the UWA Centre for Medical Research (affiliated with the Harry Perkins Institute of Medical Research), he focuses on pharmacogenomics in pediatric cancer treatment.

Education: Doctor of Philosophy, School of Allied Health, University of Western Australia.

Research interests include methotrexate pharmacogenomics, CRISPR/Cas9 genomic models for drug efficacy assessment, and systematic reviews addressing gaps in pediatric cancer therapies. His work aligns with UN Sustainable Development Goals related to health and well-being.

Publications include two peer-reviewed abstracts in the Asia-Pacific Journal of Clinical Oncology (2019), exploring methotrexate pharmacogenomics in pediatric cancers and a CRISPR-based genomic model. He received the Churchill Fellowship 2022 for pharmacogenomics research.

Grants: Co-investigator on two major projects funded by the Western Australian Department of Health, focusing on personalized cancer treatment using pharmacogenomics to improve outcomes and reduce costs for seriously ill children (MiSSK initiative).

Labs/Teams: Involved with the Centre for Optimisation of Medicines and collaborates with the Harry Perkins Institute of Medical Research.